To be better leaders, the administration should engage its primary audience: the faculty. Graphic by Miguel Tovar/University of Houston

The world of academic research is tough. As institutional research offices juggle regulatory and financial challenges within a continually strained system, they still have to lead their respective enterprises and serve their research communities.

“Service before leadership,” said Amr Elnashai, vice president/vice chancellor for research and technology transfer at the University of Houston. “We cannot miss this very important fact – we have to serve the needs of our research communities, first, before they will trust us to lead.”

How can we better serve faculty while tackling the many challenges faced by research divisions?

Sara Bible, associate vice provost for research at Stanford University, says the best way is to continually engage faculty in the business of research.

Rule making within research

Let’s be honest – faculty don’t particularly enjoy the administrative overburden dished out by university research offices. Nor should they.

But involving faculty in the process is the quickest way to earn their cooperation.

“You will have good results if you put in the time,” said Bible. “It’s really important to be flexible with faculty and staff on campus.”

One way Bible has successfully engaged her research community is in policy development. Her office at Stanford implemented a research policy working group that spends months testing policy language and effectiveness with university faculty and staff before it is launched.

“We’ve had great results,” she said. “People want to engage and be part of the process, not just be expected to follow a rigid set of rules.”

The pre-deadline deadline

Another way to partner with faculty is to work with them to improve the proposal review cycle, for everyone knows the risks of pushing the magic button mere minutes before the deadline.

Melinda Cotton, assistant vice president for Sponsored Programs at the University of Alabama at Birmingham, recommends creating a pre-deadline deadline.

Her office worked with faculty, schools and departments to establish the submission of proposals a full seven days before their due dates. This gave the office time to strengthen merit of the research project and fix minor details that could disqualify a proposal.

“Within our School of Medicine, more than 80 percent of our proposals came in by our pre-deadline,” she said. “We work hard to communicate and advocate to faculty that we can serve them better by doing it this way, and it’s working for us.”

Ultimately, there are lots of processes university research offices have to put in place to do the business of research. But to be better leaders, the administration should engage its primary audience: the faculty.

Engagement in policy-making, for instance, gives insight into pain points and allows research offices to put the best processes in place to get the job done for everyone.

------

This article originally appeared on the University of Houston's The Big Idea. Lindsay Lewis, the author of this piece, formerly served as the executive director of communications for the UH Division of Research.


Faculty in academia shouldn't be hesitant to follow their entrepreneurial goals just because it may be difficult to balance the two worlds. Graphic by Miguel Tovar/University of Houston

University of Houston: Tips for balancing faculty and founder life

Houston voices

Finding balance in your professional life and your dreams can be hard for anyone. Faculty in academia, hoping to become entrepreneur and start their own companies, find this especially difficult. Finding this balance is essential to having success both professionally and in entrepreneurial endeavors.

Amy J. Ko, a professor at the University of Washington Information School and Co-Founder of AnswerDash, said in a post on her Bits and Behavior blog that she found parallels between being an entrepreneur and being a professor that helped her start her technology company.

Here are four parallels between startup life and faculty life that Ko found striking.

1. Fundraising.

"I spend a significant amount of my time seeking funding, carefully articulating problems with the status quo and how my ideas will solve these problems. The surface features of the work are different—in business, we pitch these ideas in slide decks, elevators, whereas in academia, we pitch them as NSF proposals and DARPA white papers—but the essence of the work is the same: it requires understanding the nature of a problem well enough that you can persuade someone to provide you resources to understand it more deeply and ultimately address it."

2. Experimentation.

"Research requires a high degree of iteration and experimentation, driven by carefully formed hypotheses. Startups are no different. We are constantly generating hypotheses about our customers, our end users, our business plan, our value, and our technology, and conducting experiments to verify whether the choice we've made is a positive or negative one."

3. Learning.

"Both academia and startups require a high degree of learning. As a professor, I'm constantly reading and learning about new discoveries and new technologies that will change the way I do my own research. As a founder, and particularly as a CTO, I find myself engaging in the same degree of constant learning, in an effort to perfect our product and our understanding of the value it provides."

4. Teaching.

"The teaching I do as a CTO is comparable to the teaching I do as a Ph.D. advisor in that the skills I'm teaching are less about specific technologies or processes, and more about ways of thinking about and approaching problems."

Ko also mentions the distinct differences between the two are the pace, the outcomes, and the consequences.

Finding Balance as a Professor and Entrepreneur

Alaina G. Levine, an award-winning entrepreneur, science journalist, and STEM careers consultant said in a Science Mag blog post that the key to success is to find ways to balance the two worlds.

"Issues of intellectual property ownership, human resources protocols, and time management, as well as the challenge of keeping a delineated barrier between professorial and business activities can be difficult to manage, but these concerns shouldn't prevent academics from seeking to create a startup company," Levine said in the blog post.

How to Balance Entrepreneurship and Faculty Responsibilities

According to Levine, these are a few things to consider before perusing entrepreneurship in order to successfully balance professorial and entrepreneurial activities:

1. Know your priorities

"If you are a professor who ponders whether your research can be developed into a technology that can be commercialized, your initial step should be to ponder your priorities. Do you want to stay in academia? Do you desire a career in industry? Deciding these choices early on, even before the lawyers and university representatives get involved, is crucial to forging a balance and a satisfying career."

2. Figuring out what path to take

"To wrangle the options and make it through the multiverse of marketing and manufacturing without sacrificing professorial duties, an academic's initial stop should be their institution's office of technology transfer (OTT). The OTT can assist faculty with understanding how much time they can spend on outside endeavors and how it must be structured. Technology transfer professionals also provide insight into patent law and can help professors navigate intellectual property (IP) issues."

3. Managing potential conflicts of interest

"Once you engage in entrepreneurship, you must create a distinct separation between your university lab and your company's facilities. IP can't flow freely between the two, and neither can labor—your grad students cannot work for you in your group and intern at your company at the same time. Safeguards that prevent mingling are necessary for legal purposes, say experts, as well as to synthesize a balance between being in academia and being in business."

4. Getting a Return on Investment on the faculty side

"Even with a targeted separation of academic and business endeavors, pursuing commercialization can actually enhance your skills in education. The connections that faculty make not only help the students but benefit the department and university as a whole as well."

What's The Big Idea?

Faculty in academia shouldn't be hesitant to follow their entrepreneurial goals just because it may be difficult to balance the two worlds. Take what you already know as a professor and apply it to your new venture as an entrepreneur. Also, know where your priorities lie, what path you're taking, watch out for conflicts of interest and make sure you, your students and university are all getting something out of it.

According to both writers, universities and research go hand in hand and both are "of critical importance" to the advancement of our society. So, is your research impactful? If the answer is yes, go for it.

------

This article originally appeared on the University of Houston's The Big Idea. Cory Thaxton is the communications coordinator for The Division of Research.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”